首页|TIPS联合置管溶栓(或联合局部处理)治疗门静脉血栓临床疗效

TIPS联合置管溶栓(或联合局部处理)治疗门静脉血栓临床疗效

Clinical efficacy of TIPS combined with catheter thrombolysis or local treatment for portal vein thrombosis

扫码查看
目的 探讨经颈静脉肝内门体静脉分流术(TIPS)联合置管溶栓的临床疗效.方法 回顾性分析我院 2016 年 1 月至 2019 年 12 月收治的 307 例门静脉高压症合并门静脉血栓(PVT)患者成功行TIPS联合留置导管溶栓的临床疗效.通过术中测量分流前后下腔静脉压力(inferior vena cava pressure,ICVP)、分流前后门静脉压力(portal vein pressure,PVP),分别计算分流前、分流后(溶栓前)及溶栓后门静脉压力梯度(portal pressure gradient,PPG)(PPG=PVP-IVCP),通过再次DSA下行门静脉造影观察PVT消失程度及分流道是否通畅.所有患者均按时随访 1 年.结果 分流前、分流后(溶栓前)及溶栓后平均PPG分别为(24.50±6.91)mmHg、(18.51±5.11)mmHg 及(10.17±3.97)mmHg,溶栓后 PPG 明显低于溶栓前PPG,具有显著的统计学意义(P<0.001);307 例患者中,PVT完全消失者占 72.3%(221/307)、显著减少者占 27.7%(86/307)、无无效病例;分流道血流完全通畅者占 85.7%(261/307),部分通畅者占 14.3%(46/307);发生合并症 42 例,无死亡病例.全部患者均随访 1 年.临床症状改善情况:所有患者主要临床症状均有所改善或完全消失.其中 17 例患者(5.5%)血栓较术后增加,经TIPS分流道对血栓进行局部处理联合置管溶栓,全部患者分流道恢复至第一次术后水平.肝性脑病发生情况:术后 1 年内发生显性肝性脑病(OHE)17.6%(54/307).生存情况:术后 9 个月及 11 个月因肝功能衰竭及脑出血分别死亡 1 例,其他患者全部生存.结论 门静脉高压症合并PVT患者行TIPS联合置管溶栓效果良好,安全.应加强全流程系统化管理.
Objective To investigate the clinical efficacy of transjugular intrahepatic portosystemic shunt(TIPS)combined with indwelling catheter-directed thrombolysis for the treatment of portal vein thrombosis(PVT).Methods The clinical efficacy of 307 patients with portal hypertension complicated by PVT,who received successful TIPS combined with indwelling catheter-directed thrombolysis at the Affiliated Beijing Shijitan Hospital of Capital Medical University of China between January 2016 and December 2019,were retrospectively analyzed.Before and after TIPS,the inferior vena cava pressure(IVCP)and portal vein pressure(PVP)were measured,and the pre-TIPS,post-TIPS(before thrombolysis),and post-thrombolysis portal pressure gradient(PPG,PPG=PVP-IVCP)was separately calculated.Reexamination of portal venography DSA was performed to determine the degree of PVT disappearance and whether the shunt was unobstructed.All patients were followed up for one year.Results The pre-TIPS,post-TIPS(before thrombolysis),and post-thrombolysis mean PPG was(24.50±6.91)mmHg,(18.51±5.11)mmHg,and(10.17±3.97)mmHg,respectively.The post-thrombolysis mean PPG was strikingly lower than the pre-thrombolysis values,the differences were statistically significant(P<0.001).Among the 307 patients,complete disappearance of PVT was observed in 221(72.3%),remarkable reduction of PVT in 86(27.7%),and no invalid result was seen.The patients having complete patency of the shunt flow accounted for 85.7%of the 307 patients(261/307),and the patients having partial patency of the shunt flow accounted for 14.3%of the 307 patients(46/307).Forty-two patients developed complications,and no death occurred.All patients were followed up for one year,and the main clinical symptoms were improved or completely disappeared.Among the 307 patients,an increase in thrombus volume was found in 17(5.5%)when compared to their postoperative values,which returned to the first-time postoperative level after local treatment of the thrombus via the TIPS shunt combined with catheter-directed thrombolysis.Within one year after TIPS and thrombolysis,overt hepatic encephalopathy(OHE)occurred in 54 patients(17.6%,54/307).One patient died of hepatic failure 9 months after TIPS,another patient died of cerebral hemorrhage 11 months after TIPS,and all the remaining patients were alive.Conclusion For patients with portal hypertension complicated by PVT,TIPS combined with indwelling catheter-directed thrombolysis is clinically safe and effective.The standardized,systematic management of the whole therapeutic process should be strengthened.(J Intervent Radiol,2024,32:22-27)

portal vein thrombosistransjugular intrahepatic portosystemic shuntindwelling catheterthrombolysis

崔婷、王涛、张裕、张丹、岳振东、王磊、范振华、吴一凡、董成宾、刘福全

展开 >

100038 北京 首都医科大学附属北京世纪坛医院介入治疗科

烟台毓璜顶医院介入治疗科

门静脉血栓 TIPS 留置导管 溶栓

2024

介入放射学杂志
上海市医学会

介入放射学杂志

CSTPCD北大核心
影响因子:1.866
ISSN:1008-794X
年,卷(期):2024.33(1)
  • 8